The country has recently introduced six tax cuts.
Release time:
2020-08-14
country recently introduced six tax reduction policies
The executive meeting of the State Council held before the 4th decided to implement 6 tax reduction policies, including a series of tax reduction measures consisting of "1+4+6 ", of which "1+4 " is the first policy to be implemented. "1 " refers to the simplified value-added tax rate; "4 " refers to four new income tax reduction policies, including expanding the scope of small and micro enterprises enjoying preferential corporate income tax, increasing the proportion of pre-tax deduction for research and development expenses of small and medium-sized technology-based enterprises, launching pilot projects on tax policies for venture capital enterprises and angel investment individuals, and promoting pilot projects on pre-tax deduction of personal income tax for commercial health insurance; "6 " refers to the preferential policy of urban land use tax for bulk commodity storage facilities of logistics enterprises, the exemption of value-added tax for cable TV viewing fees, the exemption of value-added tax for interest income from small loans to farmers in financial institutions, the deduction of value-added tax for entrepreneurship and employment of key groups, the deduction of value-added tax for entrepreneurship and employment of retired soldiers, and the exemption of value-added tax for Xinjiang International Bazaar Project. The main contents are as follows:
1 ) continue to promote the VAT reform and simplify the VAT rate structure. Starting from 7 May 1 this year, the VAT rate will be reduced from four grades to 17% , 11% and 6% , and the tax rate of 13% will be canceled. The VAT rate for agricultural products and natural gas will be reduced from 13% to 11% . At the same time, the original deduction for the purchase of agricultural products by agricultural deep processing enterprises will remain unchanged, so as to avoid increasing the tax burden due to the reduction of input deduction.
2 ) Expand the scope of small and low-profit enterprises that enjoy corporate income tax benefits. From 2017 1 August 1 to 2019 12 April 31 , the annual taxable income limit of small profit-making enterprises will be increased from 30 yuan to 50 yuan, the income of small profit-making enterprises that meet this condition is halved to calculate the taxable income and pay enterprise income tax at the preferential tax rate of 20% .
3 ) Increase the percentage of pre-tax deductions for R & D expenses for technology-based SMEs. From 2017 January 1 to 2019 12 July 31 , the proportion of research and development expenses actually incurred by small and medium-sized technology-based enterprises in developing new technologies, new products and new processes before enterprise income tax will be increased from 50% to 75% .
4 ) Venture capital enterprises in the pilot area can enjoy preferential policies for investment in seed and start-up technology enterprises. Pilot projects will be carried out in Beijing-Tianjin-Hebei, Shanghai, Guangdong, Anhui, Sichuan, Wuhan, Xi 'an, Shenyang comprehensive innovation and reform pilot areas and Suzhou Industrial Park. Starting from February this year, venture capital enterprises that invest in seed-stage and start-up technology-based enterprises can enjoy a preferential policy of deducting taxable income by 70% of the investment amount; starting from August this year, the investors enjoying this preferential policy will be expanded from corporate partners of corporate and partnership venture capital enterprises to individual investors. Investments made within 2 years before the policy comes into effect can also enjoy the above-mentioned preferential treatment. ( 5 ) The pilot policy of pre-tax deduction of personal income tax for commercial health insurance has been extended to the whole country. Starting from July 1, 108, September, 110 1, 111 this year, the pilot policy of pre-tax deduction of personal income tax for commercial health insurance will be extended to the whole country, allowing pre-tax deduction of personal expenses for purchasing eligible commercial health insurance products at a maximum limit of 2,400 yuan per year for .
( 6 ) extends some tax incentives that expire at the end of 2016 to the end of 2019 . The main contents include: halving the urban land use tax on the land for bulk commodity storage facilities owned by logistics enterprises; exempting the interest income of small loans of farmers in financial institutions from value-added tax, and expanding the scope of this preferential policy to all legal compliance Micro-loan companies operating; entrepreneurship and employment for key groups such as college graduates, people with employment difficulties, and retired soldiers, deduction of value-added tax, urban maintenance and construction tax, education surcharge and individual (enterprise) income tax, etc. in accordance with the provisions.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page